First Look Analysts Research Calls for Thursday, January 26
This report was sent to Briefing.com subscribers earlier today. Upgrades: > FibroGen (FGEN) upgraded to Outperform from Mkt Perform at Raymond James; tgt $35 Downgrades: > easyJet (ESYJY) downgraded to Mkt Perform from Outperform at Bernstein > EVgo Inc. (EVGO)…
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> FibroGen (FGEN) upgraded to Outperform from Mkt Perform at Raymond James; tgt $35
Downgrades:
> easyJet (ESYJY) downgraded to Mkt Perform from Outperform at Bernstein
> EVgo Inc. (EVGO) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $6
> Hyatt Hotels (H) downgraded to Equal Weight from Overweight at Wells Fargo; tgt raised to $113
> Lending Club (LC) downgraded to Neutral from Buy at Janney; tgt $10
> Popular (BPOP) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $74
Others:
> Albemarle (ALB) initiated with an Overweight at Piper Sandler; tgt $310
> Datadog (DDOG) initiated with an Overweight at Cantor Fitzgerald; tgt $95
> Dexcom (DXCM) initiated with an Outperform at Wolfe Research; tgt $121
> Dyne Therapeutics (DYN) initiated with a Buy at Guggenheim; tgt $33
> Exelixis (EXEL) initiated with an Outperform at Credit Suisse; tgt $29
> JFrog (FROG) initiated with an Overweight at Cantor Fitzgerald; tgt $29
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.
